Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #20,081 to #20,130.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Cancer/testis antigen 55 [407 bytes]
  2. (hist) Cryopyrin-associated periodic syndrome primary prevention [407 bytes]
  3. (hist) Progeria other diagnostic studies [407 bytes]
  4. (hist) Subependymal giant cell astrocytoma echocardiography and ultrasound [407 bytes]
  5. (hist) COVID-19-associated heart failure electrocardiogram [407 bytes]
  6. (hist) Hypoangiotensinemia [408 bytes]
  7. (hist) Maternal-fetal medicine [408 bytes]
  8. (hist) Helminth protein [408 bytes]
  9. (hist) Polybutylene [408 bytes]
  10. (hist) FFANY Shoes on Sale [408 bytes]
  11. (hist) Pharmaceutical Society of Northern Ireland [408 bytes]
  12. (hist) Swedish Sign Language [408 bytes]
  13. (hist) Klinični center Ljubljana [408 bytes]
  14. (hist) Functional symptom [408 bytes]
  15. (hist) Carbamoyl phosphate synthase [408 bytes]
  16. (hist) Fluorenylmethyloxycarbonylchloride [408 bytes]
  17. (hist) Meiocyte [408 bytes]
  18. (hist) Congenital adrenal hyperplasia CT [408 bytes]
  19. (hist) Congenital adrenal hyperplasia primary prevention [408 bytes]
  20. (hist) Congenital adrenal hyperplasia cost-effectiveness of therapy [408 bytes]
  21. (hist) Congenital adrenal hyperplasia future or investigational therapies [408 bytes]
  22. (hist) Mesothelioma cost-effectiveness of therapy [408 bytes]
  23. (hist) Mesothelioma future or investigational therapies [408 bytes]
  24. (hist) Mucoepidermoid carcinoma cost-effectiveness of therapy [408 bytes]
  25. (hist) Mucoepidermoid carcinoma future or investigational therapies [408 bytes]
  26. (hist) Pancreatic cancer cost-effectiveness of therapy [408 bytes]
  27. (hist) Reactive arthritis screening [408 bytes]
  28. (hist) Leukocytosis historical perspective [408 bytes]
  29. (hist) Pancreatic cancer case study one [408 bytes]
  30. (hist) Mallory-Weiss syndrome cost-effectiveness of therapy [408 bytes]
  31. (hist) Mallory-Weiss syndrome future or investigational therapies [408 bytes]
  32. (hist) Mallory-Weiss syndrome case study one [408 bytes]
  33. (hist) Proctitis differential diagnosis [408 bytes]
  34. (hist) Dermatofibroma secondary prevention [408 bytes]
  35. (hist) Renal oncocytoma screening [408 bytes]
  36. (hist) Hypogonadism secondary prevention [408 bytes]
  37. (hist) Pseudohypoparathyroidism other imaging findings [408 bytes]
  38. (hist) Respiratory failure other imaging findings [408 bytes]
  39. (hist) Post-streptococcal glomerulonephritis surgery [408 bytes]
  40. (hist) Foodborne illness case study one [408 bytes]
  41. (hist) Foodborne illness physical examination [408 bytes]
  42. (hist) Foodborne illness medical therapy [408 bytes]
  43. (hist) Foodborne illness cost-effectiveness of therapy [408 bytes]
  44. (hist) Foodborne illness secondary prevention [408 bytes]
  45. (hist) Reactive arthritis case study one [408 bytes]
  46. (hist) Kyasanur forest disease medical therapy [408 bytes]
  47. (hist) HIV coinfection with hepatitis b other diagnostic studies [408 bytes]
  48. (hist) Primary amoebic meningoencephalitis case study one [408 bytes]
  49. (hist) Primary amoebic meningoencephalitis cost-effectiveness of therapy [408 bytes]
  50. (hist) Primary amoebic meningoencephalitis surgery [408 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)